Leading Pharma's business development team explores partnership and licensing opportunities in the areas of finished dosage, active pharmaceutical ingredients, and authorized generics. We perform a comprehensive analysis of each proposal to ensure maximum impact upon launch.

Our goal is to build a superior product line across a wide range of therapeutic areas. We are always eager to hear from manufacturers of finished dosage pharmaceuticals and APIs as well as development companies who are interested in partnering and licensing. Leading Pharma also considers ANDA/NDA divestiture opportunities.

If you have a business development opportunity that you think would be a good match for our company, we’d love to hear from you. Please contact Chief Business Officer Brian Shapiro at bshapiro@leadingpharma.com.

• Partnership and licensing
• ANDA/NDA divestiture
• Authorized Generics (AG)
• Complete front-end sales and marketing to ensure maximum market share